ArticleEmerging infectious diseases2021
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020.
Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Diagnostic challenges in COVID 19 and dengue co-infection: a case series report from tertiary care centers of Saudi Arabia.Frontiers in medicine · 2026Article
- Dengue-SARS-CoV-2 interactions: immune crosstalk, variant emergence, and clinical outcomes.Frontiers in immunology · 2026Review
- Lessons and concerns about the SARS-CoV-2/DENV co-infection.BMC infectious diseases · 2025Article
- Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach.Frontiers in immunology · 2025Article
- Epidemiology of Dengue in Argentina during the 2010/11 to 2019/20 Seasons: A Contribution to the Burden of Disease.Tropical medicine and infectious disease · 2024Article
- Analysis of a non-integer order mathematical model for double strains of dengue and COVID-19 co-circulation using an efficient finite-difference method.Scientific reports · 2023Article
- Co-Infection between Dengue Virus and SARS-CoV-2 in Cali, Colombia.The American journal of tropical medicine and hygiene · 2023Article
- SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management.Reviews in medical virology · 2023Review
- Article
- Two viruses in a pod: a case series of coinfection of COVID-19 with dengue.Oxford medical case reports · 2022Article
- Black Fungus and beyond: COVID-19 associated infections.Clinical imaging · 2022Review
- Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia.Tropical diseases, travel medicine and vaccines · 2022Article
- Dengue and COVID-19: Managing Undifferentiated Febrile Illness during a "Twindemic".Tropical medicine and infectious disease · 2022Article
- Pulmonary hemorrhage in dengue: differential diagnosis with acute viral respiratory syndromes including COVID-19.Revista do Instituto de Medicina Tropical de Sao Paulo · 2022Article
- Coinfection and cross-reaction of dengue and COVID-19: a case series analysis.Revista da Sociedade Brasileira de Medicina Tropical · 2022Article
- Article
- Double Trouble: Dengue Followed by COVID-19 Infection Acquired in Two Different Regions: A Doctor's Case Report and Spatial Distribution of Cases in Presidente Prudente, São Paulo, Brazil.Tropical medicine and infectious disease · 2021Article
- Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.Cellular and molecular life sciences : CMLS · 2021Review
- Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.Frontiers in immunology · 2021Article
- COVID-19 and dengue coinfection in Veracruz, Mexico.Travel medicine and infectious diseaseArticle
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An epidemic of dengue virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infections occurred in Argentina during 2020. We describe the clinical characteristics and outcomes in a cohort of patients hospitalized because of co-infection. We retrospectively identified 13 patients from different hospitals in Buenos Aires who had confirmed infection with SARS-CoV-2 and dengue virus and obtained clinical and laboratory data from clinical records. All patients had febrile disease when hospitalized. Headache was a common symptom. A total of 8 patients had respiratory symptoms, 5 had pneumonia, and 3 had rash. Nearly all patients had lymphopenia when hospitalized. No patients were admitted to an intensive care unit or died during follow up. Co-infection with SARS-CoV-2 and dengue virus can occur in patients living in areas in which both viruses are epidemic. The outcome of these patients did not seem to be worse than those having either SARS-CoV-2 or dengue infection alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.